Turnstone Biologics Corp. Deferred Offering Costs
Turnstone Biologics Corp. had Deferred Offering Costs of $0 as of 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Balance Sheet › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-03-22
- 2023-12-31: Deferred Offering Costs $0.00.
- 2023-09-30: Deferred Offering Costs $0.00.
- 2023-06-30: Deferred Offering Costs $4.40M.
- 2022-12-31: Deferred Offering Costs $1.90M.
| Period end | Deferred Offering Costs |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-22 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.40M 10-Q · filed 2023-09-01 |
| 2022-12-31 | $1.90M 10-K · filed 2024-03-22 |